A Validation Study on IDO Immune Biomarkers for Survival Prediction in Non-Small Cell Lung Cancer: Radiation Dose Fractionation Effect in Early-Stage Disease

Wang Weili; Huang Lei; Jin Jian-Yue; Pi Wenhu; Ellsworth Susannah G.; Jolly Shruti; Mellor Andrew L.; Machtay Mitchell; Kong Feng-Ming (Spring)

首页> 外文期刊>Clinical cancer research: an official journal of the American Association for Cancer Research >A Validation Study on IDO Immune Biomarkers for Survival Prediction in Non-Small Cell Lung Cancer: Radiation Dose Fractionation Effect in Early-Stage Disease

【24h】

A Validation Study on IDO Immune Biomarkers for Survival Prediction in Non-Small Cell Lung Cancer: Radiation Dose Fractionation Effect in Early-Stage Disease

机译：非小细胞肺癌生存预测的IDO免疫生物标志物的验证研究：早期疾病中的辐射剂量分馏作用

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose: We recently reported that indoleamine 2, 3-dioxygen-ase (IDO) activity is significantly correlated with more distant metastasis and worse survival. The present study examined whether radiotherapy (RT) dose fractionation correlates with IDO-mediated immune activity in patients with early-stage NSCLC.

机译：目的：我们最近报道，吲哚胺2,3-二恶英-ASE（IDO）活性与更远距离转移和更差的存活率显着相关。本研究检查了放射治疗（RT）剂量分馏是否与早期NSCLC患者的IDO介导的免疫活性相关。

著录项

来源
《Clinical cancer research: an official journal of the American Association for Cancer Research》 |2020年第1期|共8页
作者
Wang Weili; Huang Lei; Jin Jian-Yue; Pi Wenhu; Ellsworth Susannah G.; Jolly Shruti; Mellor Andrew L.; Machtay Mitchell; Kong Feng-Ming (Spring);
展开▼
作者单位

Univ Hosp Cleveland Med Ctr Seidman Canc Ctr Dept Radiat Oncol Cleveland OH 44106 USA;

Newcastle Univ Fac Med Sci Inst Cellular Med Newcastle Upon Tyne Tyne &

Wear England;

Univ Hosp Cleveland Med Ctr Seidman Canc Ctr Dept Radiat Oncol Cleveland OH 44106 USA;

Indiana Univ Sch Med Dept Radiat Oncol Indianapolis IN 46202 USA;

Indiana Univ Sch Med Dept Radiat Oncol Indianapolis IN 46202 USA;

Univ Michigan Dept Radiat Oncol Ann Arbor MI 48109 USA;

Newcastle Univ Fac Med Sci Inst Cellular Med Newcastle Upon Tyne Tyne &

Wear England;

Univ Hosp Cleveland Med Ctr Seidman Canc Ctr Dept Radiat Oncol Cleveland OH 44106 USA;

Univ Hosp Cleveland Med Ctr Seidman Canc Ctr Dept Radiat Oncol Cleveland OH 44106 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词
入库时间 2022-08-19 23:44:50

相似文献

外文文献
中文文献
专利

1. A Validation Study on IDO Immune Biomarkers for Survival Prediction in Non-Small Cell Lung Cancer: Radiation Dose Fractionation Effect in Early-Stage Disease [J] . Wang Weili, Huang Lei, Jin Jian-Yue, Clinical cancer research: an official journal of the American Association for Cancer Research . 2020,第1期

机译：非小细胞肺癌生存预测的IDO免疫生物标志物的验证研究：早期疾病中的辐射剂量分馏作用
2. Angiogenesis Biomarkers are Associated with Distant Metastasis Free Survival in Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy (SBRT) [J] . Bloom J., Borgia J., Blumenfeld P. A., International Journal of Radiation Oncology, Biology, Physics . 2018,第3Suppla期

机译：血管生成生物标志物与患有立体定向体放射治疗（SBRT）处理的早期非小细胞肺癌中的远期非小细胞肺癌的远程转移生存息有关
3. Effect of Radiation Therapy Dose Fractionation on IDO Immune Status in Early Stage Non-Small Cell Lung Cancer [J] . Wang W., Jin J. Y., Pi W., International Journal of Radiation Oncology, Biology, Physics . 2018,第3Suppla期

机译：放射治疗剂量分馏对早期非小细胞肺癌IDO免疫状态的影响
4. Development and validation of a radiomics nomogram for progression-free survival prediction in stage IV EGFR-mutant non-small cell lung cancer [C] . Jiangdian Song, Yali Zang, Weimin Li, Conference on Computer-Aided Diagnosis . 2017

机译：放射组学诺模图的开发和验证，用于IV期EGFR突变非小细胞肺癌的无进展生存期预测
5. Enhancing the Therapeutic Effects of Low Doses of Ionizing Radiation in Non-Small Cell Lung Cancers Using a Combination of PARP Inhibitors and DNA Demethylating Agents. [D] . Biondi, Christopher Anthony. 2016

机译：使用PARP抑制剂和DNA去甲基化剂的组合增强非小细胞肺癌低剂量电离辐射的治疗效果。
6. Radiation dose and survival of patients with stage IV non-small cell lung cancer undergoing concurrent chemotherapy and thoracic three-dimensional radiotherapy: reanalysis of the findings of a single-center prospective study [O] . Wei-Wei Ouyang, Sheng-Fa Su, Yin-Xiang Hu, 2014

机译：Ⅳ期非小细胞肺癌同时化疗和胸腔三维放疗患者的放射剂量和存活率：单中心前瞻性研究结果的重新分析
7. A Validation Study on IDO Immune Biomarkers for Survival Prediction in Non–Small Cell Lung Cancer: Radiation Dose Fractionation Effect in Early-Stage Disease [O] . Weili Wang, Lei Huang, Jian-Yue Jin, 2019

机译：非小细胞肺癌生存预测的IDO免疫生物标志物的验证研究：早期疾病中的辐射剂量分馏作用

A Validation Study on IDO Immune Biomarkers for Survival Prediction in Non-Small Cell Lung Cancer: Radiation Dose Fractionation Effect in Early-Stage Disease

摘要

著录项

相似文献

相关主题

期刊订阅